Showing results (41-50 of 198) with videos related to

Sort By:
Pageof 20
American Journal of Industrial Medicine|January 29, 2002
Time dependent memory decayPaul Jenkins, Giulia Earle-Richardson, David Tucker Slingerland, et al.
British Journal of Haematology|March 10, 2020
The UK NCRI study of chlorambucil, mitoxantrone and dexamethasone (CMD) versus fludarabine, mitoxantrone and dexamethasone (FMD) for untreated advanced stage follicular lymphoma: molecular response strongly predicts prolonged overall survivalMark J Bishton, Simon Rule, William Wilson, et al.
Advances in Therapy|October 7, 2017
Subcutaneous Rituximab for the Treatment of B-Cell Hematologic Malignancies: A Review of the Scientific Rationale and Clinical DevelopmentAndrew Davies, Claude Berge, Axel Boehnke, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|June 23, 2015
Unusual trend in the prevalence of trisomy 13 in mothers aged 35 and older: A population based study of national congenital anomaly dataDeepa Balachandran Nair, David Tucker, Rhian Hughes, et al.
Frontiers in Cardiovascular Medicine|August 2, 2021
Contribution of Congenital Heart Disorders Associated With Copy Number Variants in Mediating Risk for Brain Developmental Disorders: Evidence From 20-Year Retrospective Cohort StudyLuke Dowden, David Tucker, Sian Morgan, et al.
Ecology and Evolution|November 1, 2018
Discovered and disappearing? Conservation genetics of a recently named Australian carnivorous marsupialThomas Y Mutton, Susan J Fuller, David Tucker, et al.
Haematologica|December 25, 2016
Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphomaAndrew Grigg, Martin J S Dyer, Marcos González Díaz, et al.
Plos One|November 19, 2019
Antidepressant prescriptions, discontinuation, depression and perinatal outcomes, including breastfeeding: A population cohort analysisSue Jordan, Gareth I Davies, Daniel S Thayer, et al.
Clinical Pharmacokinetics|November 18, 2011
Effect of cytochrome P450 3A4 inducers on the pharmacokinetic, pharmacodynamic and safety profiles of bortezomib in patients with multiple myeloma or non-Hodgkin's lymphomaAndrzej Hellmann, Simon Rule, Jan Walewski, et al.
The Journal of Infection|March 29, 2011
Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy?Simon D Goldenberg, Nicholas M Price, David Tucker, et al.
Pageof 20